Antithrombin-lowering in hemophilia: a closer look at fitusiran

Gene therapy in haemophilia: literature review and regional perspectives for Turkey - Kaan Kavaklı, Bülent Antmen, Vahap Okan, Fahri Şahin, Selin Aytaç, Can Balkan, Ergül Berber, Zühre Kaya, Alphan Küpesiz, Bülent Zülfikar

PDF) An investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B

Bleeding episodes significantly reduced in study of hemophilia drug

Antithrombin-lowering in hemophilia: a closer look at fitusiran - ScienceDirect

A Molecular Revolution in the Treatment of Hemophilia. - Abstract - Europe PMC

PDF) Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy

Fitusiran Prophylaxis for Patients With Hemophilia A or B

Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial - The Lancet

Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation